Stryker Corp. (SYK)
303.13
-4.86
(-1.58%)
USD |
NYSE |
Sep 04, 16:00
305.10
+1.97
(+0.65%)
Pre-Market: 20:00
Stryker Research and Development Expense (Quarterly) : 424.00M for June 30, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 424.00M |
| March 31, 2026 | 404.00M |
| December 31, 2025 | 380.00M |
| September 30, 2025 | 398.00M |
| June 30, 2025 | 396.00M |
| March 31, 2025 | 393.00M |
| December 31, 2024 | 342.00M |
| September 30, 2024 | 364.00M |
| June 30, 2024 | 352.00M |
| March 31, 2024 | 356.00M |
| December 31, 2023 | 328.00M |
| September 30, 2023 | 335.00M |
| June 30, 2023 | 319.00M |
| March 31, 2023 | 311.00M |
| December 31, 2022 | 284.00M |
| September 30, 2022 | 317.00M |
| June 30, 2022 | 323.00M |
| March 31, 2022 | 306.00M |
| December 31, 2021 | 331.00M |
| September 30, 2021 | 306.00M |
| June 30, 2021 | 310.00M |
| March 31, 2021 | 288.00M |
| December 31, 2020 | 255.00M |
| September 30, 2020 | 242.00M |
| June 30, 2020 | 233.00M |
| Date | Value |
|---|---|
| March 31, 2020 | 254.00M |
| December 31, 2019 | 254.00M |
| September 30, 2019 | 246.00M |
| June 30, 2019 | 246.00M |
| March 31, 2019 | 225.00M |
| December 31, 2018 | 221.00M |
| September 30, 2018 | 221.00M |
| June 30, 2018 | 216.00M |
| March 31, 2018 | 204.00M |
| December 31, 2017 | 205.00M |
| September 30, 2017 | 198.00M |
| June 30, 2017 | 192.00M |
| March 31, 2017 | 192.00M |
| December 31, 2016 | 189.00M |
| September 30, 2016 | 184.00M |
| June 30, 2016 | 183.00M |
| March 31, 2016 | 159.00M |
| December 31, 2015 | 164.00M |
| September 30, 2015 | 155.00M |
| June 30, 2015 | 154.00M |
| March 31, 2015 | 152.00M |
| December 31, 2014 | 153.00M |
| September 30, 2014 | 153.00M |
| June 30, 2014 | 158.00M |
| March 31, 2014 | 150.00M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Intuitive Surgical, Inc. | 370.40M |
| Zimmer Biomet Holdings, Inc. | 104.80M |
| Abbott Laboratories | 892.00M |
| Becton, Dickinson & Co. | 258.00M |
| Boston Scientific Corp. | 554.00M |